FTC Says Shire ViroPharma’s Abuse Of FDA Process Violated Antitrust Law

Mealey's (February 15, 2017, 10:19 AM EST) -- WILMINGTON, Del. — The U.S. Federal Trade Commission on Feb. 7 filed an antitrust complaint against Shire ViroPharma Inc., alleging that the company engaged in abusive petitioning of and litigation with...
To view the full article, register now.